Actuate Therapeutics, Inc.
ACTU
$7.67
-$0.01-0.13%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.87% | 9.47% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.23% | -2.95% | |||
| Operating Income | 6.23% | 2.95% | |||
| Income Before Tax | 5.82% | 2.00% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 5.82% | 2.00% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 5.82% | 2.00% | |||
| EBIT | 6.23% | 2.95% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 6.54% | 1.73% | |||
| Normalized Basic EPS | 6.52% | 1.75% | |||
| EPS Diluted | 6.54% | 1.73% | |||
| Normalized Diluted EPS | 6.52% | 1.75% | |||
| Average Basic Shares Outstanding | 0.76% | -0.26% | |||
| Average Diluted Shares Outstanding | 0.76% | -0.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||